反応式
Cl[C:2]1[CH:3]=[C:4]([F:24])[C:5]2[N:6]([C:8]([CH2:11][C:12]3[CH:13]=[C:14]4[C:19](=[CH:20][CH:21]=3)[N:18]=[CH:17][C:16]([O:22]C)=[CH:15]4)=[N:9][N:10]=2)[CH:7]=1.[CH3:25][N:26]1[CH:30]=[C:29](B2OC(C)(C)C(C)(C)O2)[CH:28]=[N:27]1.C([O-])([O-])=O.[Na+].[Na+].O>COCCOC.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2].C(Cl)Cl.CS(C)=O>[F:24][C:4]1[C:5]2[N:6]([C:8]([CH2:11][C:12]3[CH:13]=[C:14]4[C:19](=[CH:20][CH:21]=3)[N:18]=[CH:17][C:16]([OH:22])=[CH:15]4)=[N:9][N:10]=2)[CH:7]=[C:2]([C:29]2[CH:28]=[N:27][N:26]([CH3:25])[CH:30]=2)[CH:3]=1参加物
8
反応物 4
生成物 1
試薬・触媒・溶媒 3
反応条件
- 温度
- 100 °C
実験手順
A mixture of crude 6-((6-chloro-8-fluoro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)methyl)-3-methoxyquinoline (200 mg, 584 μmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (600 mg, 2884 μmol), PdCl2(dppf)-CH2Cl2 adduct (24 mg, 29 μmol), and Na2CO3 (500 mg, 4717 μmol) in DME (7 mL)-H2O (5 mL) was heated at 100° C. under nitrogen. After overnight, the sludge was treated with DMSO (10 mL) and filtered. The DMSO solution was purified on HPLC (10-60%/10 min). The product fraction was concentrated to dryness with toluene. The solid was then triturated with MeOH-hexane (1:2) to give a brown powder (60 mg). LCMS (ESI pos. ion): calc'd for C20H15FN6O: 374.1. found 375.1 (M+1).
後処理
- filtrationfiltered
- customThe DMSO solution was purified on HPLC (10-60%/10 min)
- concentrationThe product fraction was concentrated to dryness with toluene
- customThe solid was then triturated with MeOH-hexane (1:2)
出典と根拠
- ORDレコード
- ord-4b4849fbabb24ce8a12c2fd00689ee17
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08524900B2
関連ノート
読み込み中…